Plunkett Research Online: Oragenics Inc

ORAGENICS INC (OGEN:ASE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Oragenics, Inc., formerly known as Oragen, Inc. is a multifaceted biopharmaceutical company focused on the discovery, development and commercialization of a variety of products and technologies. The firm plans to take each technology on a case-by-case basis to determine the appropriate path to maxim.....



Oragenics Inc
Ticker: OGEN
Exchange: ASE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 813 286-7900
Fax:
Address: 4902 Eisenhower Boulevard
Suite 125
Tampa, FL 33634 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
Alan JoslynCEO/President/Director
Michael SullivanCFO/Chief Accounting Officer/Secretary/Treasurer
See More
Oragenics, Inc., formerly known as Oragen, Inc. is a multifaceted biopharmaceutical company focused on the discovery, development and commercialization of a variety of products and technologies. The firm plans to take each technology on a case-by-case basis to determine the appropriate path to maxim.....See More See More

Auditor: Mayer Hoffman McCann P.C.
Legal Advisor: Shumaker, Loop & Kendrick, LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: